Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Melanoma Management|November 22, 2018
Combatting mucosal melanoma: recent advances and future perspectivesHelen Tyrrell, Miranda PayneBiochemical Society Transactions|May 16, 2009
Genomic instability and cancer: lessons from analysis of Bloom's syndromeMiranda Payne, Ian D HicksonRheumatology (Oxford, England)|December 10, 2019
Toxicities associated with checkpoint inhibitors-an overviewLaura Spiers, Nicholas Coupe, Miranda PayneEuropean Journal of Cancer Care|March 29, 2022
Implications of systemic adjuvant melanoma treatments for U.K. melanoma services: Results of the U.K. Melanoma Adjuvant Pathway SurveyOliver Cassell, Catherine Harwood, Melanie Hovey, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trialMiranda Payne, Paul Ellis, David Dunlop, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2009
Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancerMiranda Payne, Penny Bradbury, Bethan Lang, et al.Therapeutic Advances in Medical Oncology|November 7, 2022
Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanomaRicky Frazer, Avinash Gupta, Christopher Herbert, et al.Frontline Gastroenterology|October 29, 2019
Immunotherapy-related hepatitis: real-world experience from a tertiary centreVincent Cheung, Tarun Gupta, Miranda Payne, et al.European Journal of Cancer (Oxford, England : 1990)|June 22, 2020
Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanomaHenry G Smith, Jessica Glen, Nancy Turnbull, et al.Pharmacoeconomics|March 20, 2017
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNigel Fleeman, Adrian Bagust, Angela Boland, et al.Pageof 3